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2Abstract
In cell transplantation therapy for the treatment of neurodegenerative disorders, encapsulation
of implanted cells in a semipermeable membrane is a promising approach to protect the implanted
cells from host immune rejection and inhibit the invasion of tumor into surrounding tissue if the
implanted cells form a tumor after transplantation. However, implanted neurons isolated by capsules
could not build connections with host neurons, preventing the implanted neurons from responding to
stimuli from host neurons. In the present study, we focused on the passage of neurites and axons
navigated by axon guidance molecules through membrane pores to enable encapsulated neurons and
host neurons to form connections. The type of matrix coated on membranes and the pore size of the
membranes greatly affected the successful passage of PC12 neurites through membrane pores. PC12
neurites preferably passed through collagen-coated membranes with pores greater than 0.8 µm in
diameter, but the neurites did not pass through albumin- or fibronectin-coated membranes or
membranes with pores less than 0.1 µm in diameter. We could navigate the direction of commissural
neural axon extensions by utilizing the axon guidance molecules secreted from floor plate and make
guided axons pass through the membrane pores. These results suggest the feasibility of building
connections between encapsulated neurons and host neurons by encapsulating the implanted neurons
and axon guidance molecules, which attract the axons of host neurons into the capsule, in the porous
membranes with suitable pore size and matrix coating.
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Introduction
    Cell transplantation to replace lost neurons is a new approach for the treatment of
neurodegenerative disorders [1]. Research in the field of Parkinson’s disease, which is characterized
by a reduction in striatal dopamine associated with the relatively selective loss of nigro-striatal
dopaminergic neurons, has spearheaded the exploitation of this approach [2-5]. Some studies have
reported a beneficial response after the transplantation of human fetal dopaminergic neurons into
patients with Parkinson’s disease. However, the feasibility of this therapy is limited by the severe
shortage of human fetal tissue and ethical problems. Development of an efficient, safe, and ethically
acceptable source of cells for transplantation is also a major issue for the treatment of other
neurological disorders such as Alzheimer’s disease, Huntington’s disease, and diabetes insipidus [6-
8]. Recently, neurons induced from stem cells are expected to be a valid alternative cell source. In
vitro studies have shown that various types of neurons could be generated from stem cells, including
human neural stem cells, human embryonic stem (ES) cells, and induced pluripotent stem (iPS) cells,
and used for the development of stem cell-based cell transplantation therapy [9-14]. However, grafts
4of cells derived from stem cells can be contaminated with residual pluripotent cell types, leading to
tumor formation in the host [15].
      The other major obstacle for cell transplantation therapy is the rejection of implanted cells by
the host immune system [16, 17]. Encapsulation of implanted cells in a semipermeable membrane
has been examined to avoid this obstacle [18, 19]. The selectively permeable nature of the polymer
membrane permits bidirectional access of low molecular weight compounds, including the inward
diffusion of oxygen and other vital nutrients and the outward diffusion of cell products such as
dopamine and insulin. The membrane restricts the passage of elements of the host immune system
including immunocompetent cells, antibodies, and complement proteins, thereby preventing host
rejection of the encapsulated cells. In addition, cell encapsulation can prevent the invasion of tumors
into surrounding tissue if implanted cells form a tumor after transplantation [20]. These benefits of
encapsulation can enable the use of stem cell-derived neurons as a cell source for transplantation.
Date et al. and Aebischer et al. demonstrated that dopamine-secreting PC12 cells, a
catecholaminergic cell line derived from rat pheochromocytoma, encapsulated in a hollow fiber and
implanted into the striatum of Parkinsonian model monkeys and adult guinea pigs, respectively,
stably provided dopamine to the striatum [21, 22]. Although the encapsulation of implanted cells has
some benefits, conventional capsules such as hollow fibers and alginic acid hydrogel prevent the
formation of synaptic connections between implanted neurons and host neurons due to the small
5pore size required to prevent the passage of antibodies and complement proteins [23, 24]. Since
neurons communicate with one another via synapses in vivo, formation of synaptic connections
between implanted neurons and host neurons is important for implanted neurons to work effectively
in response to the stimuli from host neurons.
     To enable encapsulated neurons and host neurons to form connections, we propose the
encapsulation of implanted neurons and axon guidance molecules, which can attract the axons of
host neurons into the capsule, in membranes with pores sized to allow the passage of axons in the
central nervous system with a typical 1-µm diameter but prevent the passage of immunocompetent
cells with a diameter of about 6 - 15 µm (Fig. 1). Because human cells will be used in future clinical
settings, we expect that a membrane that can prevent the passage of host immunocompetent cells,
which play a major role in the rejection of implanted allogenic cells, is sufficient. When these
encapsulated neurons are implanted into the host brain, axons of host neurons can be attracted
toward the capsule, supporting the formation of synaptic connections between encapsulated neurons
and host neurons. In the present study, we focused on the passage of neurites and axons navigated by
guidance molecules through membrane pores as a proof-of-concept demonstration of the feasibility
of our approach. First, we examined the effects of matrix coated on the membrane and the pore size
of the membrane on the passage of neurites through membrane pores by using PC12 cells. Second,
we navigated the direction of axon extension of commissural neurons by using axon guidance
6molecules secreted from the floor plate, allowing guided axons to pass through the membrane pores.
Materials and Methods
Passage of PC12 neurites through porous membranes
To examine the effect of different matrix-coated membranes on the passage of neurites through
membrane pores, polycarbonate Nuclepore® membranes with 5-µm diameter pores (thickness, 10
µm; Whatman Inc., Florham Park, NJ) were immersed overnight at 37°C in PBS solutions
containing: 0.005% polyornithine (weight-average molecular weight: 30~70 kDa; Sigma, St. Louis,
MO); 10 µg/ml mouse laminin (BD Biosciences, Bedford, MA); 10 µg/ml bovine plasma fibronectin
(Invitrogen, Carlsbad, CA); 10 µg/ml rat tail collagen Type I (BD Biosciences); or 5% bovine serum
albumin (Sigma). The membranes were then washed with PBS. To examine the effect of the
membrane pore size on the passage of neurites through the pores, polycarbonate Nuclepore®
membranes with a pore diameter of 0.05, 0.1, 0.4, 0.8, 1, or 3 µm (thickness, 6 - 10 µm; Whatman
Inc.) were immersed in 10 µg/ml collagen solution in PBS overnight at 37°C and then washed with
PBS. The presence of protein on the membrane was confirmed by using the protein staining reagent,
Coomassie brilliant blue.
7PC12 cells (JCRB0266, Health Science Research Resources Bank, Japan) were grown in
culture dishes in RPMI 1640 medium (Invitrogen) supplemented with 5% fetal bovine serum (FBS,
Invitrogen), 10% horse serum (Invitrogen), 100 U/ml penicillin, and 100 µg/ml streptomycin. The
cells were collected by pipetting and resuspended in culture medium. Then, the cells were plated on
the various matrix-coated membranes or collagen-coated membranes with various pore sizes at a
density of 6 × 104 cells/cm2. After 5 h of incubation, 2.5S-nerve growth factor (NGF, Invitrogen) at a
final concentration of 100 ng/ml was added to the culture medium, followed by cultivation for 6
days in a humidified 5% CO2 incubator at 37°C. After 6 days, cells on membranes were fixed with a
4% paraformaldehyde solution for 15 min at 4°C and then permeabilized in methanol for 15 min at
–20°C. After blocking for 1 h with 2% skimmed milk solution, the cells were incubated with rabbit
anti-β-tubulin type III (TuJ1; Babco, Richmond, CA, USA) (diluted to 1:600 with 2% skimmed milk
solution) overnight at 4°C. The samples were washed with 0.05% polyoxyethylene sorbitan
monolaurate (Tween20) three times and then incubated with FITC-labeled rabbit IgG (Jackson, West
Grove, PA) (diluted to 1:100 with 2% skimmed milk solution) for 2 h at room temperature. After
washing three times using 0.05% Tween20, cell bodies were removed from the upper membrane
surface by wiping with a cell scraper (Iwaki, Tokyo, Japan). Then, stained neurites were visualized
with a IX71 fluorescent microscope (Olympus, Tokyo, Japan) that was focused on the underside of
membranes. For quantification, the total area of stained neurites was measured by using ImageJ
8software. Five independent experiments were performed. To compare the different types of matrix,
we calculated the ratio of the total area of stained neurites on each membrane to that on the collagen-
coated membrane. For the examination of pore size, the total area of stained neurites on each
membrane was normalized by dividing the total area of stained neurites on each membrane by the
total pore area of each membrane, and the results were expressed as the ratio of the normalized total
area of stained neurites on each membrane to that on the membrane with 3-µm diameter pores. For
statistical evaluation, experimental groups were compared by analyzing the variance followed by t-
tests with Welch’s correction.
Passage of axons navigated by guidance molecules through porous membranes
The experimental procedure is schematically shown in Fig. 2. Nylon membrane with 60-µm
diameter pores and 50-µm thicknesses (2 _ 2 mm; Millipore, Tokyo, Japan) was glued vertically to
the polystyrene cell culture dishes and then washed with ethanol. Spinal cords were isolated from
E13 Wistar rat embryos by dissection in L15 medium (Invitrogen) [25]. Spinal cords were cut at the
roof plate and flattened down in an open book configuration. About 400 _ 400 µm pieces of dorsal
spinal cord and floor plate explants were harvested from opened spinal cords by using tungsten
needles in L15 medium containing 5% horse serum. Dorsal spinal cord and floor plate explants were
placed on the nylon membrane-attached substrates facing each other across the nylon membrane.
9Then, substrates were embedded in three-dimensional collagen gels and cultivated in 50% F12
medium (Invitrogen), 39% Opti-MEM (Invitrogen) and 5% horse serum supplemented with 40 mM
glucose, 100 U/ml penicillin, and 100 µg/ml streptomycin in a humidified 5% CO2 incubator at 37°C.
After a 24-h incubation period, cells were observed with an IX71 phase-contrast microscope. The
above experimental protocol was approved by the AIST’s ethical committee for animal experiment.
Results and Discussion
Effect of matrix coated on the porous membrane on passage of neurites through membrane
pores
    Matrix coated on the membrane is thought to greatly influence the passage of axons through
membrane pores. We examined the passage of extending neurites through various matrix-coated
membranes by using PC12 cells as a model. When PC12 cells are exposed to NGF, they differentiate
into sympathetic neuron-like cells, extending long neuronal-like processes [26]. After attaching the
PC12 cells to the upper side of various matrix-coated membranes and subsequently stimulating the
neurite outgrowth by the addition of the NGF, neurites stained with a neural marker, TuJ1, on the
underside of the membranes (i.e., neurites passing through the membrane pores) were observed.
Representative fluorescent images and a more quantitative assessment of neurites from PC12 cells
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extending through the pores of various matrix-coated membranes are shown in Fig. 3 and Fig. 4,
respectively. Remarkable passage of neurites was found on polyornithine-, collagen-, or laminin-
coated membrane, in contrast to the uncoated membrane (Fig. 3 a-d). Our results are consistent with
previous reports that cationic polymers, such as polyethylenimine, polyornithine, or polylysines, and
collagen- or laminin-coated substrates support the attachment of neural cells and the extension of
neurites [27-29]. On the other hand, no passage of neurites was observed on the fibronectin- or
albumin-coated membranes (Fig. 3 e, f). These results are closely related to the cell-adhesion
behavior on these membranes (Fig.5). Cell adhesion on fibronectin-coated membranes was
significantly inferior to adhesion on polyornithine-, collagen- or laminin-coated membranes.
Albumin-coated surfaces are well-known to be resistant to cell adhesion, and the PC12 cells did not
attach to the albumin-coated membranes [30]. Thus, the type of matrix coated on the membrane
significantly affects the passage of neurites, and collagen is the most effective coating for promoting
the passage of PC12 neurites (Fig. 4). It is worth mentioning that the pore diameter of the
membranes may be decreased in the range of several ten nanometers after the coating of matrix due
to the adsorption of matrix onto the pore walls in all experiments [31].
Effect of pore size of the porous membrane on the passage of neurites through membrane
pores
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    Pore size is also thought to influence the passage of axons through membrane pores. Therefore,
PC12 cells were cultured on collagen-coated membranes with various pore sizes. Representative
fluorescent images and a more quantitative assessment of neurites from PC12 cells extending
through membranes with various pore sizes are shown in Fig. 6 and Fig. 7, respectively. Remarkable
passage of neurites occurred on membranes with pore sizes larger than 0.8 µm, whereas the passage
of neurites hardly occurred with pore sizes smaller than 0.1 µm (Fig. 6 a, b, d, e, f). A small but
significant passage was found on the membranes with 0.4-µm pores (Fig. 6 c). No significant
difference in the passage of neurites was seen between membranes with 0.8-, 1-, and 3-µm pores,
and a decreased passage of neurites was observed between the membranes with 0.4- and 0.8-µm
pores; thus, pore size did not influence the passage of PC12 axons above 0.8-µm pore (Fig. 7).
Membranes with 0.8- to 3-µm diameter pores can prohibit the passage of host immunocompetent
cells, but cannot inhibit the passage of antibodies and complement proteins [32, 33]. It has been
accepted that the transplantation of allogenic cells causes the activation of cellular immunity [34].
On the other hand, humoral immunity including antibodies and complement proteins is thought to
play a major role in the rejection of implanted xenogenic cells [35]. Hence, we expect that a
membrane that can prevent the passage of host immunocompetent cells is sufficient, because human
cells will be used in future clinical settings. Although the effective type of matrix and minimum pore
size for the passage of axons may depend on the type of neurons, a suitable matrix and pore size can
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be identified by performing examinations in the same manner as in the present study.
Passage of commissural axons navigated by guidance molecules through membrane pores
During spinal cord development, commissural neurons in the dorsal spinal cord extend axons
toward the floor plate by the actions of netrin-1 and Shh secreted from the floor plate cells (Fig. 8 a)
[36, 37]. This attraction of axons at a distance by diffusible chemoattractants in vivo was reproduced
in vitro [38]. When dorsal spinal cord explants containing commissural neurons were cultured with
floor plate explants in the collagen gel matrix, commissural axons, as axon bundles, extended toward
the floor plate explants (Fig. 8 b, c), while no axon bundles were observed in the absence of floor
plate explants (Fig. 8 d). This co-culture system of dorsal spinal cord and floor plate explants was
applied as a model for displaying the passage of axons navigated by axon guidance molecules
through the membrane. Because commissural neurons extend axons as a bundled structure, we
selected the porous membrane with large-diameter pores (60 µm) for this experiment. Porous
membrane was placed between dorsal spinal cord explants and floor plate explants, and these
explants were cultured in the collagen gel matrix (Fig. 2). As shown in Fig. 8 e, f, axon bundles of
commissural neurons in dorsal spinal cord explants were attracted toward the floor plate explant,
passing through the membrane pores. Some molecular families such as Slits, Semaphorins, BMPs,
and Wnts, in addition to Netrins and Hedgehogs, have also been identified as diffusible axon
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guidance molecules, which attract or repel the axons of various types of neurons at a distance [39,
40]. These diffusible axon guidance molecules are also good candidates for controlling the direction
of axon extension, making axons pass through the membrane pores. In addition to these guidance
molecules, growth factors and extracellular matrix molecules affect axon guidance and extension.
Thus, optimization of the combination of regulating molecules for each neural subtype along with
the type of membrane is necessary to create an effective axon control system for transplantation.
Conclusions
     Here, we focused on the passage of neurites and axons navigated by axon guidance molecules
through membrane pores. Our studies of PC12 cells cultured on porous membranes show that the
type of matrix coated on the membrane and the pore size of the membrane greatly affect the
successful passage of PC12 neurites through membrane pores. Moreover, we could navigate the
direction of commissural neural axon extension by utilizing axon guidance molecules secreted from
floor plate explants and make guided axons pass through the membrane pores. These results provide
valuable information for improving capsule materials to promote connections between encapsulated
neurons and host neurons. Recently, neurons induced from stem cells have attracted much attention
as unlimited cell sources for cell transplantation therapy. A major concern with the use of stem cell-
derived neurons is their potential for tumorigenicity. Because encapsulation restricts tumorigenesis
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by physically restricting the proliferation of tumor cells, the development of cell-encapsulation
techniques may contribute to the spread of stem cell-based cell transplantation therapy.
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Figure captions
Figure 1. Concept of the cell transplantation therapy utilizing the cell-encapsulation technique and
axon guidance.
Figure 2. Schematic representation of the preparation method of explant co-culture separated by a
porous membrane.
Figure 3. Representative fluorescent images of PC12 neurites extending through pores of (a)
uncoated polycarbonate membrane, (b) polyornithine-coated membrane, (c) collagen-coated
membrane, (d) laminin-coated membrane, (e) fibronectin-coated membrane, and (f) albumin-coated
membrane. Scale bar, 100 µm.
Figure 4. Passage of PC12 neurites through various matrix-coated porous membranes. Results are
expressed as the ratio of the total area of stained neurites on each membrane to that on collagen-
coated membrane. Data are represented by the means ± SD, n=5.
Figure 5. Cell adhesion on various matrix-coated porous membranes after 5-hour cultures. Phase-
contrast micrographs of PC12 cells cultured on (a) uncoated polycarbonate membrane, (b)
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polyornithine-coated membrane, (c) collagen-coated membrane, (d) laminin-coated membrane, (e)
fibronectin-coated membrane, and (f) albumin-coated membrane. Scale bar, 200 µm.
 
Figure 6. Representative fluorescent images of PC12 neurites extending through membrane pores
with (a) 0.05-µm diameter, (b) 0.1-µm diameter, (c) 0.4-µm diameter, (d) 0.8-µm diameter, (e) 1-µm
diameter, and (f) 3-µm diameter. Scale bar, 100 µm.
Figure 7. Passage of PC12 neurites through porous membranes with various pore sizes. Results are
expressed as the ratio of the normalized total area of stained neurites on each membrane to that on
membrane with 3-µm diameter pores. Data are represented by the means ± SD, n=5. †; p < 0.0001, ††,
†††; p > 0.01.
Figure 8. Passage of axons navigated by guidance molecules through porous membranes. (a)
Schematic diagram of a cross-section of the vertebrate spinal cord. (b) Phase-contrast micrograph of
co-culture of dorsal spinal cord explants (right side) with floor plate explants (left side). (c)
Magnified view of axons extended from dorsal spinal cord explants in (b). (d) Phase-contrast
micrograph of dorsal spinal cord explants alone. (e) Phase-contrast micrograph of co-culture of
dorsal spinal cord explants (right side) with floor plate explants (left side) separated by a porous
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membrane. The arrow shows the porous membrane. (f) Magnified view of axons passing through the
membrane pores in (e). Scale bar, 200 µm.
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